Cardicomm Solutions, Inc. Press Releases

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms completion of a six month collaborative project with researchers at the University of Victoria, Canada, leading the way to a release of artificial intelligence ("AI") enhancements to CardioComm's Global ECG Management Solution ("GEMS™")...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") acquisition and management software solutions, confirms the USA Food and Drug Administration ("FDA") has reduced the scope of their request for additional information for the Company's premarket notification 510(k), Class II medical device clearance application for the HeartCheck™...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms the renewal of $600,000 in loans that would have matured December 31, 2018. The maturing loans were made to the Company in December 2016 as described in the Company's press release dated December 21, 2016. The four lenders that participated in the 2016...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company" or "CCS"), a global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, and Virginia-based connected health provider Creo Wellness, LLC (“CREO”) confirm the companies have committed to integrate CardioComm’s ECG monitoring service technologies and ECG devices to support the CREO physician...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will makes its first issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company initially announced the online marketing and awareness program in its press release dated November 8,...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has completed its ISO 13485:2016 ("ISO") certification in compliance with the Medical Device Single Audit Program ("MDSAP"), which is now mandatory under Health Canada requirements and recommended by the USA Food and Drug Administration ("FDA")....

TORONTO, ONTARIO - Established medial electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today confirmed the appointment of a new Chief Financial Officer ("CFO"), Ms. Anne Burpee. Ms. Burpee is a bilingual Chartered Professional Accountant with more than 25 years of senior finance and executive experience in both large and small companies. She has held several corporate positions in...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has completed its response to the USA Food and Drug Administration ("FDA") for additional information following the Company's filing of its premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it is implementing an online marketing and awareness program through AGORA Internet Relations Corp. ("AGORACOM"). AGORACOM's program will provide the Company a significant level of exposure through millions of content brand insertions on the...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced its joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions confirmed today progress on a royalty licencing agreement with Redwood City, California-based Biotricty Inc. ("Biotricity"). The royalty payment phase became active following confirmation that all necessary clearance and software development pre-conditions...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, firmly responds to recent technology companies' announcements that it was the first company to be approved to sell an ECG product directly to consumers over the counter ("OTC") in North America. CardioComm was the first company to be approved to sell an...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced that it is seeking approval from the TSX Venture Exchange to extend the expiry dates of outstanding warrants exercisable to purchase an aggregate of 8,346,000 common shares of the Company at $0.075 per share. 7,300,000 of the warrants were...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms its HeartCheck™ device and GEMS™ software technologies have moved into routine clinical use following completion of a long-term, remote arrhythmia monitoring pilot in high risk patients. Partners in Advanced Cardiac Evaluation...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received a request for additional information from the USA Food and Drug Administration ("FDA") following the Company's filing of its premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces that it has issued 62,500 stock options to Etienne Grima, the Company’s CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately....

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, issued 62,500 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five years from the date of grant and vest immediately. The grants are subject to the...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has filed an application with the USA Food and Drug Administration ("FDA") for premarket notification 510(k), Class II medical device clearance of the Company's newest HeartCheck™ branded, handheld heart rhythm monitor. The CardioComm...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has initiated the application process to the USA Food and Drug Administration ("FDA") for premarket notification 510(K), Class II medical device clearance of the Company's newest consumer-based and HeartCheck™ branded, hand-held heart rhythm...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) today announced that its board of directors has adopted an advance notice policy (the “Advance Notice Policy”). The purpose of the Advance Notice Policy is to provide shareholders, directors and management of the Company with direction on the procedure for shareholder nomination of directors. The Advance Notice Policy is the framework by which the Company seeks to fix a...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) is pleased to announce that it held business meetings with 25 technology companies during an Ontario Trade Delegation visit to Japan and Korea from February 20 to 27. The meetings were arranged through the assistance of the Ontario Ministry of International Trade with Global Affairs Canada representatives in Japan and Korea, the Osaka Prefecture Government, Economic Affairs Government...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) is participating in a series of meetings organized by the Ontario Trade Commission in partnership with Global Affairs Canada which has led to a delegation visit to Japan and Korea from February 20th to 27th. Through the assistance of the Trade Commission, meetings were held in November 2017 with visiting Japanese hospital representatives in Toronto in advance of CardioComm's visit to...

TORONTO, ONTARIO – Global medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), today confirmed that it has officially released GEMS™ Home Flex for HeartCheck™ ECG devices that work on either a Mac or Windows operating system. Availability of the newly released GEMS™ Home Flex will support expanded use of both the HeartCheck™ ECG PEN and the...

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the appointment of Bank of Montreal veteran Mr. Steven Benyo, CPA, CA as the newest member of the Company's Board of Directors ("BOD") and as a member of the Company's Audit and Finance Committee. Mr. Benyo is a highly experienced risk management...

This Press release is available by request only.Please Contact Us if you would like to receive a copy.

TORONTO, ONTARIO – Established medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company") today confirmed it has been recognized as one of the 10 Most Promising Patient Monitoring Solution Providers for 2017 by California-based technology magazine CIOReview. The special edition award recognizes CardioComm's ability to influence patient monitoring technologies by tackling roadblocks for the...